Drug Screening Market Analysis

Drug Screening Market Analysis

By component, the drug screening market is classified into products and drug screening services. The product segment is further categorised into analytical instruments, rapid testing devices, and consumables. The product segment dominated the market in 2022 with a revenue share of 55.7%. Increasing launch of advanced drug screening products that provide improved solutions to make testing easy, accurate, and fast have accelerated the market trends. For instance, in May 2020, Psychemedics Corporation introduced a vaping panel to detect the use of Marijuana, CBD and Nicotine. Similarly, in May 2018, Omega Laboratories introduced Omega Hair 17-panel drug test offering tests for 45 different substances.
 

Based on sample type, the drug screening market is segmented into urine, breath, oral fluids, hair, and other sample types. The oral fluids sample is expected to register around USD 6.6 billion by 2032. The segment is projected to grow at the fastest rate during the forecast period. This high growth can be attributed to the fact that oral fluids are most used sample type to detect the presence of illicit substances and provide rapid and easy detection of drugs. Additionally, it is a quicker and less invasive sample to collect at the roadside. According to NCBI 2020 survey conducted for staff as well as patients concluded that oral fluid samples are preferred over urine samples as they help save time and maintain dignity.
 

By drug type, the drug screening market is segmented into alcohol, cannabis/marijuana, amphetamines, opioids, and other drug types. The cannabis/marijuana segment held largest market share of 35.1% in 2022. This can be attributed to high usage of cannabis drugs. For instance, as per the Center for Disease Control and Prevention (CDC), marijuana is the most used federally illegal drug in the U.S. accounting for nearly 48.2 million people used it at least once in 2019. Such increasing usage of cannabis/marijuana is expected to rise the demand for cannabis drug screening, thereby resulting in high segment progress.
 

The end-use in drug screening market is divided into drug testing laboratories, workplace, hospitals, law enforcement agencies, other end-users. Drug testing laboratories dominated the market and is expected to show considerable growth of 16.1% during the analysis period. Wide acceptance of drug testing laboratories is due to their accurate results and presence of trained personnel especially in developed countries for conducting effective tests. Also, drug testing laboratories can test for the presence of any illicit substance, which is not possible with rapid tests. Thus, benefits offered by drug testing laboratories will contribute to the market expansion.
 

North America is expected to hold significant share in the drug screening industry due to the serious problem related to high levels of alcohol intake. Also, the increasing consumption of illegal drugs, the availability of government funding to combat drug abuse, and the existence of strict rules in the country will propel the regional market growth. For instance, in April 2022, Quest Diagnostics, an American clinical laboratory performed drug testing and collected 11 million unidentifiable urine, hair, and oral fluid sample results between January and December 2021. The laboratory published data for collected samples in March 2022 and reported that, 7.5% of employees testing were positive for marijuana between January and December 2021. Hence, the rising consumption of drugs among people is expected to increase the demand for drug screening tests.